Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Steroid avoidance or withdrawal for kidney transplant recipients.

The Cochrane database of systematic reviews·2026
Same author

Erratum to "Colony stimulating factor-1 receptor drives glomerular parietal epithelial cell activation in focal segmental glomerulosclerosis." Kidney International 2024;106:67-84.

Kidney international·2026
Same author

Beyond glomeruli: interstitial fibrosis and tubular atrophy predict poor renal outcomes in lupus nephritis.

Arthritis research & therapy·2026
Same author

Urinary Chemokines in the Diagnosis and Monitoring of Immune Checkpoint Inhibitor-Associated Nephritis.

International journal of molecular sciences·2026
Same author

Tacrolimus Conversion in CYP3A5*1 Expressers: From Immediate-Release to LCP Formulation.

Therapeutic drug monitoring·2025

Related Experiment Video

Updated: Jun 6, 2026

Murine Full-thickness Skin Transplantation
07:59

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

Optimal immunosuppression to prevent chronic allograft dysfunction.

Josep M Grinyó1, Oriol Bestard, Joan Torras

  • 1Department of Nephrology, Hospital Universitari de Bellvitge, University of Barcelona, IDIBELL, Barcelona, Spain. jgrinyo@bellvitgehospital.cat

Kidney International. Supplement
|December 1, 2010
PubMed
Summary

Avoiding calcineurin inhibitors (CNIs) in kidney transplants aims to prevent chronic allograft dysfunction. While CNI-free strategies show promise for graft survival, long-term data is needed to confirm safety and efficacy against immune-mediated damage.

More Related Videos

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Related Experiment Videos

Last Updated: Jun 6, 2026

Murine Full-thickness Skin Transplantation
07:59

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation Medicine

Background:

  • Chronic allograft dysfunction significantly impacts kidney graft survival.
  • Calcineurin inhibitors (CNIs) are standard immunosuppressants but cause nephrotoxicity.
  • Minimizing CNI-related nephrotoxicity is crucial for improving long-term transplant outcomes.

Purpose of the Study:

  • To review strategies for avoiding calcineurin inhibitors (CNIs) in renal transplantation.
  • To evaluate the efficacy and safety of CNI-avoidance regimens.
  • To highlight the need for long-term data on these novel immunosuppressive approaches.

Main Methods:

  • Review of clinical trials and studies on CNI-free immunosuppressive regimens.
  • Analysis of short-term and long-term outcomes, including acute rejection rates, graft function, and adverse events.
  • Comparison of different CNI-avoidance strategies, including mycophenolate mofetil-based regimens, mammalian target of rapamycin inhibitors, and belatacept.

Main Results:

  • Early CNI-free strategies using mycophenolate mofetil were associated with increased acute rejection.
  • Mammalian target of rapamycin inhibitors show potential for improved short-term graft function and parenchyma preservation, with fewer cardiovascular events and malignancies, despite a higher rejection risk.
  • Belatacept represents another promising option for CNI avoidance.

Conclusions:

  • CNI-avoidance strategies offer potential benefits in renal transplantation but require careful consideration of rejection risks.
  • Mammalian target of rapamycin inhibitors and belatacept are emerging as viable alternatives to CNIs.
  • Longer-term studies are essential to validate the sustained efficacy and safety of CNI-avoidance protocols in preventing immune-mediated graft damage.